Hydrofarm Holdings

HYFM

Market cap $4.63M

SHOEMAKERSVILLE, Pa., May 15, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its first quarter ended March 31, 2026.

A major catalyst reshaping marijuana stocks has been the U.S. government's move toward rescheduling cannabis. The shift from a Schedule I to a proposed Schedule III classification represents a significant turning point for the cannabis industry. As a result, marijuana stocks have reacted strongly to policy developments, with trading volumes and volatility increasing around regulatory news. The future outlook for cannabis stocks remains tied to three key drivers: federal reform, state-level legalization, and industry consolidation.

The ancillary cannabis sector continues to gain attention in April 2026. These companies support the industry without touching the plant. As a result, they avoid many regulatory risks associated with federal law. Meanwhile, the U.S. cannabis market keeps expanding rapidly. Industry sales have already surpassed $30 billion annually and continue growing.

SHOEMAKERSVILLE, Pa., March 27, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025.

The cannabis industry has been growing at a fast pace, and the world is taking notice. In just the US alone, the boom of the legal cannabis business has exploded. Everything from over-the-counter CBD products to THC at your local dispensary. Between the recreational and medical markets, the amount of revenue generated is in the billions. This has sparked the interest of many individuals seeking the best investment opportunities.

The momentum is building once again for marijuana stocks. Since the passing of rescheduling cannabis to class 3, investors are staying sharp. Even though this does not legalize cannabis federally, it brings more relaxed investing without stressing federal issues. The cannabis industry has been undergoing another shift due to this. At the same time, this has led more people to find the best marijuana stocks to buy and hold till the market is up.

The U.S. cannabis industry continues expanding despite periods of volatility across the sector. However, ancillary cannabis companies remain essential to the industry's infrastructure. These businesses supply equipment, nutrients, lighting, and hydroponic systems to cannabis cultivators. Because they do not touch the cannabis plant directly, ancillary companies often face fewer regulatory restrictions.

Even with legal cannabis growing in acceptance, it is still a highly volatile market. This means that most publicly traded cannabis companies exhibit unpredictable trading patterns. Now, all sectors of the stock market face volatility; it's just that the cannabis sector sees a significant portion of it. However, volatility has not stopped investors from making a profit.

Marijuana stocks are still facing a battle in the stock market. The cannabis sector has been fighting to reach higher trading levels more consistently. For some time, there has been significant volatility that has been somewhat challenging for shareholders. You would think that with legal operators showing profitability and overall success, it would follow for the public sector. However, this has not been the case in most instances.

The cannabis sector continues to evolve as 2026 begins. While plant-touching operators still face regulatory pressure, ancillary companies remain better positioned. These businesses do not grow or sell cannabis directly. Instead, they provide the tools, products, and infrastructure that the industry depends on. As a result, they often carry less regulatory risk. They also tend to survive market downturns more effectively.